医学
观察研究
药店
多学科方法
临床药学
药学保健
心理干预
医疗保健
重症监护医学
药物经济学
不利影响
癌症
家庭医学
内科学
护理部
社会学
经济
经济增长
社会科学
作者
Jeremie Zerbit,Marie Kroemer,Basile Fuchs,Marion Detroit,Justine Decroocq,Marguerite Vignon,Lise Willems,Bénédicte Deau‐Fischer,Patricia Franchi,Paul Deschamps,Adrien Contejean,Eric Grignano,Guillemette Fouquet,Rudy Birsen,Johanna Mondesir,Mathieu Rocquet,Jean‐François Huon,Rui Batista,Jeanne Marty‐Reboul,Didier Bouscary
摘要
Objective The clinical benefit of pharmaceutical cares in improving the quality-of-care outcomes is well demonstrated. Clinical pharmacy services are not systematically deployed in cancer units in the absence of economic data. The aim of this prospective, observational 1-year study was to evaluate the clinical, economic and organisational impacts of pharmaceutical care into a multidisciplinary day hospital for patients treated with oral cancer drugs. Methods All pharmacists' interventions (PI) were documented and their impact and the probability of adverse drug events were assessed using the clinical, economic and organisational tool. Results Among 360 admissions, an average of 1.81 PI per admission was accepted. Among 452 PI leading to a clinical benefit on the patient, 16.9% had a major impact, and 1.9% had an impact on survival. The large majority of PIs (87%) increased the quality-of-care organisation. The budget impact model showed a total cost savings and cost avoidance of €539,047 per year and a cost–benefit ratio of 7.07:1. The direct cost–benefit was €201,741, and the cost avoidance was €337,306. Conclusion Multidisciplinary care and pharmaceutical care are key elements to improve cancer patients' outcomes and avoid evitable healthcare costs.
科研通智能强力驱动
Strongly Powered by AbleSci AI